艾力斯:目前已有两款产品进入CMC开发阶段

证券日报
Jan 21

证券日报网讯 1月21日,艾力斯在互动平台回答投资者提问时表示,公司长期以来致力于小分子创新药物研发,在巩固提升小分子创新药物研发的基础上,近年来公司组建了大分子新药发现团队,搭建了大分子新药研发平台,进一步提升公司研发团队的创新活力。公司大分子团队多个早研项目均在高效有序推进过程中,目前已有两款产品进入CMC开发阶段,希望可以尽快申报IND。(文章来源:证券日报) 海量资讯、精准解读,尽在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10